Alpha 2.0
Login Register
» Authors » Gabrielle Campbell

Gabrielle Campbell

Explore the profile of Gabrielle Campbell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 76
Citations 1476
Followers 0
Related Specialties
Psychiatry
Neurology
General Medicine
Top 10 Co-Authors
Louisa Degenhardt
Suzanne Nielsen
Briony Larance
Raimondo Bruno
Nicholas Lintzeris
Wayne Hall
Michael Farrell
Milton Cohen
Natasa Gisev
Shane Darke
Published In
Drug Alcohol Rev
Drug Alcohol Depend
Pain Med
Med J Aust
Pain
Affiliations
Soon will be listed here.
Recent Articles
1.
A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatment
Pocuca N, Campbell G, Barnett A, Beck A, Ellem R, Quinn C, et al.
Drug Alcohol Rev . 2025 Feb; 44(3):759-771. PMID: 39930663
Introduction: Preliminary evidence supports the use of patient-reported outcome measures (PROM) and feedback for enhancing client outcomes in alcohol and other drug (AOD) treatment. However, successful implementation remains challenging. This...
2.
Three-Month Polysubstance Use Patterns Among People Enrolled in Outpatient Treatment for Methamphetamine Use
Pocuca N, Campbell G, Ellem R, Newland G, Walter Z, Dignan J, et al.
Subst Use Misuse . 2025 Jan; 60(5):775-785. PMID: 39781907
Background: Polysubstance use is common among people who use methamphetamine. This prospective study examined the three-month polysubstance use profiles among people enrolled in outpatient treatment for methamphetamine use and associated...
3.
A discrete choice experiment: Understanding patient preferences for managing chronic non-cancer pain
Campbell G, Settumba S, Hopkins R, Nielsen S, Larance B, Bruno R, et al.
Eur J Pain . 2024 Nov; 29(3):e4760. PMID: 39601351
Background: The management of chronic non-cancer pain (CNCP) is complex. Concerns about adverse effects associated with opioid pain medications and a lack of funding for holistic programs present challenges for...
4.
Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation
Pocuca N, Tisdale C, Campbell G, Beck A, Ellem R, Quinn C, et al.
Drug Alcohol Rev . 2024 Oct; 44(1):226-238. PMID: 39402789
Introduction: Routine outcome monitoring (ROM) and feedback is an evidence-supported strategy for evaluating alcohol and other drug (AOD) treatment outcomes. However, the implementation of ROM and feedback into AOD services...
5.
Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders
Campbell G, Larance B
Addiction . 2024 Aug; 119(11):1902-1903. PMID: 39177047
No abstract available.
6.
Clinical profiles of people enrolling in alcohol and other drug treatment in Australia: Do youth differ from young adults and adults?
Campbell G, Pocuca N, Newland G, Ellem R, Glasgow S, Dignan J, et al.
Drug Alcohol Rev . 2024 Aug; 43(7):2010-2020. PMID: 39159068
Introduction: To examine and compare age groups on socio-demographic, substance use, mental health, social and risk behaviour profiles of people entering alcohol and other drug (AOD) treatment in a large...
7.
The risk of repeated suicidal presentations following residential treatment for substance use disorders: A recurrent event analysis using linked administrative data
Tisdale C, De Andrade D, Leung J, Campbell G, Hides L
J Affect Disord . 2024 May; 360:364-375. PMID: 38810779
Background: Individuals seeking alcohol and other drug (AOD) treatment consistently experience higher rates of suicidal behaviours and death by suicide when compared to the general population. By linking residential AOD...
8.
'We didn't cause the opioid epidemic': The experiences of Australians prescribed opioids for chronic non-cancer pain at a time of increasing restrictions
Hopkins R, Campbell G, Degenhardt L, Gisev N
Drug Alcohol Rev . 2024 May; 43(6):1625-1635. PMID: 38803123
Introduction: Many countries have implemented strategies to reduce opioid-related harms, including policies and prescribing restrictions. This study aimed to explore the lived experiences of Australians prescribed opioids for chronic non-cancer...
9.
Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis
Santo Jr T, Gisev N, Campbell G, Colledge-Frisby S, Wilson J, Tran L, et al.
Int J Drug Policy . 2024 Apr; 128:104434. PMID: 38677160
Background: Comorbid substance use disorders (SUDs) among people with opioid use disorder (OUD) contribute to poor clinical outcomes, including overdose and mortality. We present the first systematic review and meta-analysis...
10.
Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): A cluster randomised controlled trial protocol
Abdel Shaheed C, Ivers R, Vizza L, McLachlan A, Kelly P, Blyth F, et al.
BMJ Open . 2023 Nov; 13(11):e075286. PMID: 37989377
Introduction: Low back pain (LBP) is commonly treated with opioid analgesics despite evidence that these medicines provide minimal or no benefit for LBP and have an established profile of harms....